Due to planned site maintenance, you will not be able to access our course learning management system Sunday May 19, 12AM – 4AM ET. Apologies for any inconvenience.
Chimeric antigen receptor (CAR) T-cell therapy combines tumor-specific antigen recognition and T-cell immune fighting responses to target and destroy specific malignancies. Review this huddle card in a group or individually to learn more about chimeric antigen receptor (CAR) T -cell therapy.